Pfizer Fights to Keep Their Vaccine Recipe Secret
Pfizer recently struck a licensing deal with the Medical Patents Pool which in turn can strike deals with other manufacturers to make generic versions of its Covid antiviral pill for poorer countries. But when it comes to its mRNA vaccine, Pfizer has not been so willing to share the recipe. They stand to make $36 billion in revenue this year and have said that they will increase their shipments to poor countries at adjusted prices. Stephanie Baker, senior writer at Bloomberg News, joins us for the fight over profits and the lopsided global supply of vaccines. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com